Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/XE9 stock hub

FRA/XE9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/XE9is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

810.1M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/XE9FRA/XE9

—

Loading chart…

In the news

Latest news · FRA/XE9

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-29.8

P25 n/aP50 n/aP75 n/a

ROIC-81.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/XE9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	260
Employees Change	-30%
Employees Change Percent	-10.71
Enterprise value	EUR 447.1M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 810.1M
Price	EUR 10.1
Price currency	EUR
Rev Per Employee	324,770.49x
Sic	2836
Symbol	fra/XE9
Website	https://www.xencor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-18.46%
EV Earnings	-2.99x
EV/FCF	-2.73x
EV/Sales	5.41x
FCF yield	-20.22%
P/B ratio	1.81x
P/S ratio	9.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-217.93%
EBITDA Margin	-207.27%
Gross margin	-152.18%
Gross Profit	EUR -128.5M
Net Income	EUR -149.5M
Pretax Margin	-174.61%
Profit Margin	-177.1%
Profit Per Employee	EUR -575,157
ROA	-16.16
Roa5y	-7.05
ROCE	-31.98
ROE	-29.84
Roe5y	-12.71
ROIC	-81.38
Roic5y	-32.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.57%
Cagr1y	42.29%
Cagr3y	-26.27%
Cagr5y	-20.93%
Revenue Growth	-23.48x
Revenue Growth Q	-86.2x
Revenue Growth3 Y	-0.23x
Revenue Growth5 Y	-4.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.12
Assets	EUR 639.1M
Cash	EUR 385.9M
Current Assets	EUR 409.4M
Current Liabilities	EUR 62.3M
Debt	EUR 151.9M
Debt Equity	EUR 0.34
Debt FCF	EUR -0.93
Equity	EUR 447.2M
Interest Coverage	-7.59
Liabilities	EUR 191.9M
Long Term Assets	EUR 229.6M
Long Term Liabilities	EUR 129.6M
Net Cash	EUR 370.5M
Net Cash By Market Cap	EUR 45.74
Net Cash Growth	-17.88%
Net Debt Equity	EUR -0.83
Tangible Book Value	EUR 440.6M
Tangible Book Value Per Share	EUR 5.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.57
Net Working Capital	EUR -4.4M
Quick ratio	6.22
Working Capital	EUR 355.1M
Working Capital Turnover	EUR 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	5.88%
1Y total return	42.25%
200-day SMA	10.11
3Y total return	-59.92%
50-day SMA	10.11
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.08%
All Time High	44.4
All Time High Change	-77.25%
All Time High Date	2021-02-10
All Time Low	5.6
All Time Low Change	80.36%
All Time Low Date	2025-08-12
ATR	0.35
Ch YTD	-19.2
High	10.1
High52	15.6
High52 Date	2025-12-08
High52ch	-35.26%
Low	10.1
Low52	5.6
Low52 Date	2025-08-12
Low52ch	80.36%
Ma50ch	-0.06%
Price vs 200-day SMA	-0.07%
RSI	48.3
RSI Monthly	43.12
RSI Weekly	47.96
Sharpe ratio	0.72x
Sortino ratio	1.21
Total Return	-9.51%
Tr YTD	-19.2
Tr1m	-2.88%
Tr1w	-1.94%
Tr3m	16.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -184M
Operating margin	-217.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,656,126%
Shares Insiders	1.09%
Shares Institutions	91.62%
Shares Qo Q	0.89%
Shares Yo Y	9.51%
Short Ratio	12.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -199M
Average Volume	0x
Bv Per Share	6.04
CAPEX	EUR -2M
Ch10y	5.88
Ch1m	-2.88
Ch1w	-1.94
Ch1y	42.25
Ch3m	16.09
Ch3y	-59.92
Ch5y	-69.08
Ch6m	-13.68
Change	0%
Change From Open	0
Close	10.1
Days Gap	0
Depreciation Amortization	8,806,933.3
Earnings Date	2026-08-04
EBIT	EUR -184M
EBITDA	EUR -175M
EPS	EUR -2
F Score	2
FCF	EUR -163.8M
FCF EV Yield	-36.63x
Financing CF	6,880,291
Fiscal Year End	December
Founded	1,997
Income Tax	EUR 2.1M
Investing CF	132,691,696
Is Primary Listing	0
Last Earnings Date	2026-02-25
Last Report Date	2026-03-31
Ma150	11.15
Ma150ch	-9.38%
Ma20	10.3
Ma20ch	-1.89%
Net CF	-22,201,145
Next Earnings Date	2026-08-04
Open	10.1
Ppne	74,880,980.3
Price Date	2026-05-08
Ptbv Ratio	1.84
Relative Volume	20x
Revenue	84,440,328x
SBC By Revenue	41.68x
Share Based Comp	35,190,698
Tax By Revenue	2.48x
Tr6m	-13.68%
Z Score	0.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/XE9 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/XE9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/XE9?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.6%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/XE9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

-0.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/XE9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/XE9 stock rating?

fra/XE9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/XE9 analysis?

The full report lives at /stocks/fra/XE9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/XE9?

The latest report frames fra/XE9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/XE9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.